The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 20, 2011
Filed:
Feb. 18, 2005
John Gordon Allen, Newbury Park, CA (US);
Karin Briner, Indianapolis, IN (US);
Michael Philip Cohen, Indianapolis, IN (US);
Christopher Stanley Galka, Carmel, IN (US);
Sarah Lynne Hellman, Indianapolis, IN (US);
Maria Angeles Martinez-grau, Alcobendas, ES;
Matthew Robert Reinhard, Indianapolis, IN (US);
Michael John Rodriguez, Indianapolis, IN (US);
Roger Ryan Rothhaar, Reelsville, IN (US);
Michael Wade Tidwell, Indianapolis, IN (US);
Frantz Victor, Indianapolis, IN (US);
Andrew Caerwyn Williams, Basingstoke, GB;
Deyi Zhang, Carmel, IN (US);
Michael Philip Mazanetz, Notts, GB;
John Gordon Allen, Newbury Park, CA (US);
Karin Briner, Indianapolis, IN (US);
Michael Philip Cohen, Indianapolis, IN (US);
Christopher Stanley Galka, Carmel, IN (US);
Sarah Lynne Hellman, Indianapolis, IN (US);
Maria Angeles Martinez-Grau, Alcobendas, ES;
Matthew Robert Reinhard, Indianapolis, IN (US);
Michael John Rodriguez, Indianapolis, IN (US);
Roger Ryan Rothhaar, Reelsville, IN (US);
Michael Wade Tidwell, Indianapolis, IN (US);
Frantz Victor, Indianapolis, IN (US);
Andrew Caerwyn Williams, Basingstoke, GB;
Deyi Zhang, Carmel, IN (US);
Michael Philip Mazanetz, Notts, GB;
Eli Lilly and Company, Indianapolis, IN (US);
Abstract
The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula I as selective 5-HTreceptor agonists for the treatment of 5-HTassociated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety: